Evidence map›Paper›PMID 36320473›Full record

ArticleChemical science2022

Investigating the role of the strong field ligands in [FeFe] hydrogenase: spectroscopic and functional characterization of a semi-synthetic mono-cyanide active site.

Marco Lorenzi, Joe Gellett, Afridi Zamader, Moritz Senger, Zehui Duan, Patricia Rodríguez-Maciá, Gustav Berggren

Abstract read
In one paragraph

Article in Chemical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marco LorenziDepartment of Chemistry - Ångström, Molecular Biomimetics, Uppsala University Lägerhyddsvägen 1 75120 Uppsala Sweden Gustav.berggren@kemi.uu.se.ORCID https://orcid.org/0000-0002-6592-7574
Joe GellettDepartment of Chemistry, Inorganic Chemistry Laboratory, University of Oxford South Parks Road OX1 3QR UK patricia.rodriguezmacia@chem.ox.ac.uk.
Afridi ZamaderDepartment of Chemistry - Ångström, Molecular Biomimetics, Uppsala University Lägerhyddsvägen 1 75120 Uppsala Sweden Gustav.berggren@kemi.uu.se.ORCID https://orcid.org/0000-0002-0658-7733
Moritz SengerDepartment of Chemistry - Ångström, Physical Chemistry, Uppsala University Lägerhyddsvägen 1 75120 Uppsala Sweden.ORCID https://orcid.org/0000-0001-9225-4910
Zehui DuanDepartment of Chemistry, Inorganic Chemistry Laboratory, University of Oxford South Parks Road OX1 3QR UK patricia.rodriguezmacia@chem.ox.ac.uk.
Patricia Rodríguez-MaciáDepartment of Chemistry, Inorganic Chemistry Laboratory, University of Oxford South Parks Road OX1 3QR UK patricia.rodriguezmacia@chem.ox.ac.uk.ORCID https://orcid.org/0000-0003-3513-0115
Gustav BerggrenDepartment of Chemistry - Ångström, Molecular Biomimetics, Uppsala University Lägerhyddsvägen 1 75120 Uppsala Sweden Gustav.berggren@kemi.uu.se.ORCID https://orcid.org/0000-0002-6717-6612

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial maturation of hydrogenases provides a path towards generating new semi-synthetic enzymes with novel catalytic properties. Here enzymes featuring a synthetic asymmetric mono-cyanide cofactor have been prepared using two different hydrogenase scaffolds. Their structure and reactivity was investigated in order to elucidate the design rationale behind the native di-cyanide cofactor, and by extension the second coordination sphere of the active-site pocket. Surprisingly, the choice of host enzyme was found to have a dramatic impact on reactivity. Moreover, the study shows that synthetic manipulations of the active-site can significantly increase inhibitor tolerance, as compared to native [FeFe] hydrogenase, while retaining the enzyme's native capacity for reversible catalysis.

Identifiers

PMID36320473
PMCPMC9516953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.